| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Antitumor activity of the poly(ADP-ribose) polymerase inhibitor rucaparib as monotherapy in patients with platinum-sensitive, relapsed, BRCA-mutated, high-grade ovarian cancer, and an update on safety
|
Kristeleit, Rebecca S
|
|
|
29 |
9 |
p. 1396-1404
|
article
|
| 2 |
Burden of lymphatic disease predicts efficacy of adjuvant radiation and chemotherapy in FIGO 2018 stage IIICp cervical cancer
|
Bogani, Giorgio
|
|
|
29 |
9 |
p. 1355-1360
|
article
|
| 3 |
Can somatic BRCA2 status solve a case of olaparib monotherapy resistance?
|
Pietragalla, Antonella
|
|
|
29 |
9 |
p. 1440-1445
|
article
|
| 4 |
Connecting frontline providers in Africa with distant experts to improve patients’ outcomes through Project ECHO: a successful experience in Cameroon
|
Fokom Domgue, Joel
|
|
|
29 |
9 |
p. 1446-1447
|
article
|
| 5 |
Impact of compliance with an enhanced recovery after surgery pathway on patient outcomes in open gynecologic surgery
|
Iniesta, Maria D
|
|
|
29 |
9 |
p. 1417-1424
|
article
|
| 6 |
Impact of transversus abdominis plane blocks versus non-steroidal anti-inflammatory on post-operative opioid use in ERAS ovarian cancer surgery
|
Bisch, Steven Peter
|
|
|
29 |
9 |
p. 1372-1376
|
article
|
| 7 |
Impact of tumor histology on detection of pelvic and para-aortic nodal metastasis with 18F-fluorodeoxyglucose–positron emission tomography in stage IB cervical cancer
|
Lin, Alexander J
|
|
|
29 |
9 |
p. 1351-1354
|
article
|
| 8 |
Incorporating robotic surgery into the management of ovarian cancer after neoadjuvant chemotherapy
|
Abitbol, Jeremie
|
|
|
29 |
9 |
p. 1341-1347
|
article
|
| 9 |
Intentional weight loss, weight cycling, and endometrial cancer risk: a systematic review and meta-analysis
|
Zhang, Xiaochen
|
|
|
29 |
9 |
p. 1361-1371
|
article
|
| 10 |
Laparoscopic intra-operative ultrasound-guided bilateral salpingo-oophorectomy in a BRCA2 mutated patient
|
Bruno, Matteo
|
|
|
29 |
9 |
p. 1448
|
article
|
| 11 |
Management of recurrent ovarian cancer: when platinum-based regimens are not a therapeutic option
|
Bergamini, Alice
|
|
|
29 |
9 |
p. 1431-1436
|
article
|
| 12 |
Minimally invasive interval cytoreductive surgery: it’s time for a randomized trial
|
Melamed, Alexander
|
|
|
29 |
9 |
p. 1339-1340
|
article
|
| 13 |
Myeloid-derived suppressor cells at diagnosis may discriminate between benign and malignant ovarian tumors
|
Coosemans, An
|
|
|
29 |
9 |
p. 1381-1388
|
article
|
| 14 |
Perceptions, expectations, and experiences of gynecological cancer patients: a pan-European ESGO-ENGAGe survey
|
Urkmez, Esra
|
|
|
29 |
9 |
p. 1425-1430
|
article
|
| 15 |
Pre-operative opioid use in gynecologic oncology: a common comorbidity relevant to the peri-operative period
|
Ross, Megan Elizabeth
|
|
|
29 |
9 |
p. 1411-1416
|
article
|
| 16 |
Prognostic significance of PD-1 and PD-L1 positive tumor-infiltrating immune cells in ovarian carcinoma
|
Buderath, Paul
|
|
|
29 |
9 |
p. 1389-1395
|
article
|
| 17 |
Prognostic significance of supraclavicular lymphadenopathy in patients with high-grade serous ovarian cancer
|
Cybulska, Paulina
|
|
|
29 |
9 |
p. 1377-1380
|
article
|
| 18 |
Role of optimal cytoreduction in patients with dysgerminoma
|
Bandala-Jacques, Antonio
|
|
|
29 |
9 |
p. 1405-1410
|
article
|
| 19 |
Sentinel lymph node consensus document of the British Gynaecological Cancer Society for endometrial, vulvar, and cervical cancers
|
Fotopoulou, Christina
|
|
|
29 |
9 |
p. 1348-1350
|
article
|
| 20 |
Sentinel lymph node in apparent early ovarian cancer: open technique
|
Lago, Victor
|
|
|
29 |
9 |
p. 1449
|
article
|
| 21 |
Sentinel-node biopsy in early stage ovarian cancer: a prospective multicentre study (SELLY)
|
Scambia, Giovanni
|
|
|
29 |
9 |
p. 1437-1439
|
article
|
Journal description